Xintela AB (publ) (XINT.ST)
XINT.ST Stock Price Chart
Explore Xintela AB (publ) interactive price chart. Choose custom timeframes to analyze XINT.ST price movements and trends.
XINT.ST Company Profile
Discover essential business fundamentals and corporate details for Xintela AB (publ) (XINT.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 Mar 2016
Employees
21.00
Website
https://www.xintela.seCEO
Evy Lundgren-Åkerlund Assoc.Prof, BSc,
Description
Xintela AB (publ), a biomedical company, operates in the fields of regenerative medicine and cancer, focusing on cartilage damage and brain tumors. The company develops products based on XINMARK, a patented marker technology that identifies and selects a range of stem cells, which can develop cartilage cells. It is also developing XSTEM a stem cell product that is in clinical development phase for the treatment of knee osteoarthritis and difficult-to-heal leg ulcers; and EQSTEM, a stem cell product for the treatment of joint diseases in horses, as well as focuses on the preclinical development of therapeutic antibodies for aggressive cancers, including brain tumor glioblastoma and triple negative breast cancer. Xintela AB (publ) was founded in 2009 and is based in Lund, Sweden.
XINT.ST Financial Timeline
Browse a chronological timeline of Xintela AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 23 May 2025
EPS came in at -kr 0.01 matching the estimated -kr 0.01.
Earnings released on 31 Dec 2024
EPS came in at -kr 0.02 , while revenue for the quarter reached kr 1.09M .
Earnings released on 30 Sept 2024
EPS came in at -kr 0.01 , while revenue for the quarter reached kr 2.82M .
Earnings released on 29 Jun 2024
EPS came in at -kr 0.02 surpassing the estimated -kr 0.11 by +81.82%, while revenue for the quarter reached kr 4.00K .
Earnings released on 8 May 2024
EPS came in at -kr 0.02 surpassing the estimated -kr 0.04 by +51.53%, while revenue for the quarter reached kr 299.00K .
Earnings released on 30 Dec 2023
EPS came in at -kr 0.03 surpassing the estimated -kr 0.04 by +30.33%, while revenue for the quarter reached kr 78.00K .
Earnings released on 30 Sept 2023
EPS came in at -kr 0.02 .
Earnings released on 30 Jun 2023
EPS came in at -kr 0.06 .
Earnings released on 31 Mar 2023
EPS came in at -kr 0.05 .
Earnings released on 31 Dec 2022
EPS came in at -kr 0.09 .
Earnings released on 30 Sept 2022
EPS came in at -kr 0.10 .
Earnings released on 30 Jun 2022
EPS came in at -kr 0.14 .
Stock split effective on 21 Jun 2022
Shares were split 212 : 125 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Mar 2022
EPS came in at -kr 0.11 .
Earnings released on 31 Dec 2021
EPS came in at -kr 0.18 .
Earnings released on 30 Sept 2021
EPS came in at -kr 0.07 .
Earnings released on 30 Jun 2021
EPS came in at -kr 0.08 .
Earnings released on 31 Mar 2021
EPS came in at -kr 0.06 .
Earnings released on 26 Feb 2021
EPS came in at -kr 0.08 .
Earnings released on 31 Dec 2020
EPS came in at -kr 0.44 .
XINT.ST Stock Performance
Access detailed XINT.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.